{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:07:52Z","timestamp":1785906472468,"version":"3.56.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shahid Behesti University of Medical Sciences","award":["10307"],"award-info":[{"award-number":["10307"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40360-019-0316-8","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:02:59Z","timestamp":1562155379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Acute versus chronic methotrexate poisoning; a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"given":"Arman","family":"Ahmadzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4370-0544","authenticated-orcid":false,"given":"Hossein","family":"Hassanian-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Kaveh","family":"Hadeiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaz","family":"Parhizgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"316_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/BF03160968","volume":"4","author":"SW Smith","year":"2008","unstructured":"Smith SW, Nelson LS. Case files of the new York City poison control center: antidotal strategies for the management of methotrexate toxicity. J Med Toxicol. 2008;4:132\u201340.","journal-title":"J Med Toxicol"},{"key":"316_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF03161192","volume":"4","author":"F LoVecchio","year":"2008","unstructured":"LoVecchio F, Katz K, Watts D, Wood I. Four-year experience with methotrexate exposures. J Med Toxicol. 2008;4:149\u201350.","journal-title":"J Med Toxicol"},{"key":"316_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21:1471\u201382.","journal-title":"Oncologist"},{"key":"316_CR4","first-page":"2011","volume":"26","author":"S Badurdeen","year":"2011","unstructured":"Badurdeen S, Kang SL, Saravanan M. Accidental methotrexate ingestion in a 19-month-old child. BMJ Case Rep. 2011;26:2011.","journal-title":"BMJ Case Rep"},{"key":"316_CR5","unstructured":"Toxbase, UK National Poisons Information Service. \n                    http:\/\/www.toxbase.org\/Poisons-Index-A-Z\/M-Products\/Methotrexate\n                    \n                  . Accessed 16 Dec 2018."},{"key":"316_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13075-015-0668-4","volume":"17","author":"V Dhir","year":"2015","unstructured":"Dhir V, Sandhu A, Kaur J, Pinto B, Kumar P, Kaur P, et al. Comparison of two different folic acid doses with methotrexate\u2014a randomized controlled trial (FOLVARI study). Arthritis Res Ther. 2015;17:156.","journal-title":"Arthritis Res Ther"},{"key":"316_CR7","unstructured":"Firestein G, Budd R, Gabriel SE, McInnes IB, O'Dell J. Kelley and Firestein\u2019s Text book of Rheumatology. 10th ed: Elsevier; 2017. p. 963."},{"key":"316_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0049-0172(98)80049-8","volume":"27","author":"AE van Ede","year":"1998","unstructured":"van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum. 1998;27:277\u201392.","journal-title":"Semin Arthritis Rheum"},{"key":"316_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/art.1780290703","volume":"29","author":"JM Kremer","year":"1986","unstructured":"Kremer JM, Galivan J, Streckfuss A, Kamen B. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum. 1986;29:832\u20135.","journal-title":"Arthritis Rheum"},{"key":"316_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I","volume":"41","author":"WA Bleyer","year":"1978","unstructured":"Bleyer WA. The clinical pharmacology of methotrexate: new applications of an old drug. Cancer. 1978;41:36\u201351.","journal-title":"Cancer"},{"key":"316_CR11","first-page":"1009","volume":"22","author":"CA Wallace","year":"1995","unstructured":"Wallace CA, Sherry DD. A practical approach to avoidance of methotrexate toxicity [editorial]. J Rheumatol. 1995;22:1009\u201312.","journal-title":"J Rheumatol"},{"issue":"3","key":"316_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/art.1780370304","volume":"37","author":"Joel M. Kremer","year":"1994","unstructured":"Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, et al (1994) Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology [see comments]. Arthritis Rheum 37:316\u2013328.","journal-title":"Arthritis & Rheumatism"},{"key":"316_CR13","first-page":"104","volume":"2","author":"R Sotoudehmanesh","year":"2010","unstructured":"Sotoudehmanesh R, Anvari B, Akhlaghi M, Shahraeeni S, Kolahdoozan S. Methotrexate hepatotoxicity in patients with rheumatoid arthritis. Middle East J Dig Dis. 2010;2:104\u20139.","journal-title":"Middle East J Dig Dis"},{"key":"316_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mpo.2950020313","volume":"2","author":"WH Isacoff","year":"1976","unstructured":"Isacoff WH, Townsend CM, Eiber FR, Forster T, Morton DL, Block JB. High dose methotrexate therapy of solid tumors: observations relating to clinical toxicity. Med Pediatr Oncol. 1976;2:319\u201325.","journal-title":"Med Pediatr Oncol"},{"key":"316_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.reaurg.2009.06.018","volume":"18","author":"S Retenauer","year":"2009","unstructured":"Retenauer S, chauveau D, R\u00e9cher C. High-dose methotrexate: toxicity, management and prevention. Reanimation. 2009;18:654\u20138.","journal-title":"Reanimation"},{"key":"316_CR16","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1001\/archinte.1989.00390060140032","volume":"149","author":"GC Doolittle","year":"1989","unstructured":"Doolittle GC, Simpson KM, Lindsley HB. Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritis. Arch Intern Med. 1989;149:1430\u20131.","journal-title":"Arch Intern Med"},{"issue":"2","key":"316_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/15563650.2016.1271126","volume":"55","author":"BS Chan","year":"2017","unstructured":"Chan BS, Dawson AH, Buckley NA. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning? Clin Toxicol (Phila). 2017;55(2):88\u201396.","journal-title":"Clin Toxicol (Phila)"},{"key":"316_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ced.12572","volume":"40","author":"RE Ferner","year":"2015","unstructured":"Ferner RE. Adverse drug reactions in dermatology. Clin Exp Dermatol. 2015;40:105\u20139 quiz 109-10.","journal-title":"Clin Exp Dermatol"},{"key":"316_CR19","first-page":"689","volume-title":"Goldfrank\u2019s Toxicologic emergencies","author":"RY Wang","year":"2015","unstructured":"Wang RY. Chemotherapeutics: methotrexate. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank\u2019s Toxicologic emergencies. 10th ed. New York: McGraw-Hill; 2015. p. 689\u201392.","edition":"10"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-019-0316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-019-0316-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-019-0316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T23:38:16Z","timestamp":1593646696000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-019-0316-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1186\/s40360-019-0316-8","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"assertion":[{"value":"31 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was supported by Social Determinants of Health Research Center, and approved by Shahid Beheshti University of Medical Sciences Ethics Committee, Tehran, Iran (IR.SBMU.RETECH.REC.1397.428). It complies with the Declaration of Helsinki; our local ethics committee has approved the research protocol and written informed consent was obtained from the subjects on arrival time.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}